The influence of comorbid conditions on racial disparities in endometrial cancer survival

American Journal of Obstetrics and Gynecology

Volumn 211, Issue 6, 2014, Pages 627.e1-627.e9

  Ruterbusch, Julie J ^a,b   Ali Fehmi, Rouba ^a,b   Olson, Sara H ^d   Sealy Jefferson, Shawnita ^a,b   Rybicki, Benjamin A ^c   Hensley Alford, Sharon ^c   Elshaikh, Mohamed A ^c   Gaba, Arthur R ^c   Schultz, Daniel ^c   Munkarah, Adnan R ^c   Cote, Michele L ^a,b  

^a KARMANOS CANCER INSTITUTE   (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c HENRY FORD HEALTH SYSTEM   (United States)

^d MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

comorbid condition; disease specific survival; endometrial cancer; hypertension; racial disparity

Indexed keywords

ADULT; AGED; ARTICLE; BLACK PERSON; CANCER MORTALITY; CANCER PROGNOSIS; CANCER SURVIVAL; CAUCASIAN; CHARLSON COMORBIDITY INDEX; COMORBIDITY; CONTROLLED STUDY; DEMOGRAPHY; DIABETES MELLITUS; ENDOMETRIUM CANCER; FEMALE; HEALTH CENTER; HEALTH HAZARD; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MEDICAL HISTORY; MEDICAL INFORMATION; MEDICAL RECORD REVIEW; MIDDLE AGED; MORBID OBESITY; OVERALL SURVIVAL; PRIORITY JOURNAL; RACE; RACE DIFFERENCE; RETROSPECTIVE STUDY; URBAN AREA; ADENOCARCINOMA; ADENOCARCINOMA, CLEAR CELL; ADENOCARCINOMA, MUCINOUS; AFRICAN AMERICAN; CARCINOMA, ENDOMETRIOID; COHORT ANALYSIS; DISEASE FREE SURVIVAL; ENDOMETRIAL NEOPLASMS; ETHNOLOGY; HEALTH DISPARITY; MORTALITY; OBESITY; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; PROTECTION; RISK FACTOR; STATISTICS AND NUMERICAL DATA;

ADENOCARCINOMA; ADENOCARCINOMA, CLEAR CELL; ADENOCARCINOMA, MUCINOUS; AFRICAN AMERICANS; AGED; CARCINOMA, ENDOMETRIOID; COHORT STUDIES; COMORBIDITY; DIABETES MELLITUS; DISEASE-FREE SURVIVAL; ENDOMETRIAL NEOPLASMS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HEALTH STATUS DISPARITIES; HUMANS; HYPERTENSION; MIDDLE AGED; OBESITY; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROTECTIVE FACTORS; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 84923047460     PISSN: 00029378     EISSN: 10976868     Source Type: Journal    
DOI: 10.1016/j.ajog.2014.06.036     Document Type: Article

References (22)

1. R. Siegel, J. Ma, Z. Zou, and A. Jemal Cancer statistics, 2014 CA Cancer J Clin 64 2014 9 29
2. Howlader N, Noone AM, Krapcho M, et al, ed. SEER Cancer Statistics Review, 1975-2010, National Cancer Institute. Bethesda, MD. Based on November 2012 SEER data submission, posted to the SEER web site. Available at: http://seer.cancer.gov/csr/1975-2010/. Accessed April 1, 2013.
3. H.A. Hill, J.W. Eley, L.C. Harlan, R.S. Greenberg, R.J. Barrett 2nd, and V.W. Chen Racial differences in endometrial cancer survival: the black/white cancer survival study Obstet Gynecol 88 1996 919 926
4. O.W. Yap, and R.P. Matthews Racial and ethnic disparities in cancers of the uterine corpus J Natl Med Assoc 98 2006 1930 1933
5. B. Long, F.W. Liu, and R.E. Bristow Disparities in uterine cancer epidemiology, treatment, and survival among African Americans in the United States Gynecol Oncol 130 2013 652 659
6. V.W. Setiawan, M.C. Pike, L.N. Kolonel, A.M. Nomura, M.T. Goodman, and B.E. Henderson Racial/ethnic differences in endometrial cancer risk: the multiethnic cohort study Am J Epidemiol 165 2007 262 270
7. T.C. Randall, and K. Armstrong Differences in treatment and outcome between African-American and white women with endometrial cancer J Clin Oncol 21 2003 4200 4206
8. M.L. Hicks, J.L. Phillips, and G. Parham The National Cancer Data Base report on endometrial carcinoma in African-American women Cancer 83 1998 2629 2637
9. J.D. Wright, J. Fiorelli, and P.B. Schiff Racial disparities for uterine corpus tumors: changes in clinical characteristics and treatment over time Cancer 115 2009 1276 1285
10. T. Madison, D. Schottenfeld, S.A. James, A.G. Schwartz, and S.B. Gruber Endometrial cancer: socioeconomic status and racial/ethnic differences in stage at diagnosis, treatment, and survival Am J Public Health 94 2004 2104 2111
11. M.E. Sherman, and S.S. Devesa Analysis of racial differences in incidence, survival, and mortality for malignant tumors of the uterine corpus Cancer 98 2003 176 186
12. J.E. Allard, and G.L. Maxwell Race disparities between black and white women in the incidence, treatment, and prognosis of endometrial cancer Cancer control 16 2009 53 56
13. C.D. Fryar, R. Hirsch, M.S. Eberhardt, S.S. Yoon, and J.D. Wright Hypertension, high serum total cholesterol, and diabetes: racial and ethnic prevalence differences in U.S. adults, 1999-2006 NCHS Data Brief 36 2010 1 8
14. Z. Nicholas, N. Hu, J. Ying, P. Soisson, M. Dodson, and D.K. Gaffney Impact of comorbid conditions on survival in endometrial cancer Am J Clin Oncol 37 2014 131 134
15. S.H. Olson, C.L. Atoria, and M.L. Cote The impact of race and comorbidity on survival in endometrial cancer Cancer Epidemiol Biomarkers Prev 21 2012 753 760
16. M.E. Charlson, P. Pompei, K.L. Ales, and C.R. MacKenzie A new method of classifying prognostic comorbidity in longitudinal studies: development and validation J Chronic Dis 40 1987 373 383
17. U.C. McMenamin, L.J. Murray, M.M. Cantwell, and C.M. Hughes Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in cancer progression and survival: a systematic review Cancer Causes Control 23 2012 221 230
18. E.S. Diaz, B.Y. Karlan, and A.J. Li Impact of beta blockers on epithelial ovarian cancer survival Gynecol Oncol 127 2012 375 378
19. R.G. Elmore, Y. Ioffe, D.R. Scoles, B.Y. Karlan, and A.J. Li Impact of statin therapy on survival in epithelial ovarian cancer Gynecol Oncol 111 2008 102 105
20. B. Maiti, M.N. Kundranda, T.P. Spiro, and H.A. Daw The association of metabolic syndrome with triple-negative breast cancer Breast Cancer Res Treat 121 2010 479 483
21. E. Kheterpal, J.D. Sammon, and M. Diaz Effect of metabolic syndrome on pathologic features of prostate cancer Urol Oncol 31 2013 1054 1059
22. K.A. Moses, O.A. Utuama, M. Goodman, and M.M. Issa The association of diabetes and positive prostate biopsy in a US veteran population Prostate Cancer Prostatic Dis 15 2012 70 74